Chemotherapy News and Research

Latest Chemotherapy News and Research

Research unlocks the role of macrophages in cancer relapse

Researchers from the Cancer Science Institute of Singapore at the National University of Singapore (NUS), have achieved breakthroughs in understanding relapse after chemotherapy for a type of cancer known as diffuse large B-cell lymphoma (DLBCL).

13 May 2024

New insights into Chaga mushroom's mechanisms for fighting oral cancer

The mechanisms behind the anti-tumor activity of Chaga mushroom extracts in HSC-4 human oral cancer cells.

13 May 2024

Long-term Finnish study explores the association between premature menopause and mortality

Women who enter menopause before the age of 40 are more likely to die young, but may lower their risk with hormone therapy, according to research presented at the 26th European Congress of Endocrinology in Stockholm.

13 May 2024

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, "Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy."

10 May 2024

Chemotherapy linked to physical decline in older women with high-risk breast cancer

A UCLA-led study suggests women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function.

10 May 2024

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy. This marks a significant advancement in the therapeutic landscape for cervical cancer, highlighting the potential of antibody-drug conjugates (ADCs) in oncology.

From Sino Biological Inc. 10 May 2024

AML patients at the extremes of older age derive benefit from VEN-HMA regimen

Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.

9 May 2024

Exploring microbiome dynamics in esophageal cancer

Esophageal cancer (EC) has two primary subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC).

9 May 2024

UQ's AMTAR hub advances the development of hyper-accurate cancer drugs

A range of hyper accurate cancer drugs is in production at a newly opened research and manufacturing hub at The University of Queensland.

7 May 2024

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary.

7 May 2024

Innovative nanoparticle breaks blood-brain barrier to target breast cancer and brain metastases

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a nanoparticle that can penetrate the blood-brain barrier.

6 May 2024

Novel vaccine approach targets AML and other blood cancers

Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of the body's immunodefense system, white blood cells.

3 May 2024

Study supports the consideration of 177Lu-PSMA-617 as new standard treatment for metastatic prostate cancer

In a follow-on analysis of results from the phase 3 PSMAfore study, clinical investigators from Dana-Farber and elsewhere found that clinical outcomes consistently favored 177Lu-PSMA-617 over a change from one androgen receptor pathway inhibitor (ARPI) to another, regardless of which ARPI patients received first.

3 May 2024

Chemotherapy News and Research

Latest Chemotherapy News and Research

Research unlocks the role of macrophages in cancer relapse

New insights into Chaga mushroom's mechanisms for fighting oral cancer

Long-term Finnish study explores the association between premature menopause and mortality

Expanding treatment horizons for hypermutated urothelial carcinomas beyond immunotherapy

Chemotherapy linked to physical decline in older women with high-risk breast cancer

FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer

AML patients at the extremes of older age derive benefit from VEN-HMA regimen

Exploring microbiome dynamics in esophageal cancer

UQ's AMTAR hub advances the development of hyper-accurate cancer drugs

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

Innovative nanoparticle breaks blood-brain barrier to target breast cancer and brain metastases

Novel vaccine approach targets AML and other blood cancers

Study supports the consideration of 177Lu-PSMA-617 as new standard treatment for metastatic prostate cancer

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

First FDA-approved cellular therapy for metastatic melanoma available in South Florida

New biomarker predicts immunotherapy response in gastrointestinal cancers

Toxic gas adds to a long history of pollution in Southwest Memphis

The role of biological age in lung cancer treatment decision making for elderly patients

First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer

Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in